Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting-Reference-Cited by-同舟云学术

Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting

Published:2021-10-21 Issue:1 Volume:101 Page:147-154
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Mendes Fernanda Rodrigues,da Silva Wellington Fernandes,da Costa Bandeira de Melo Raphael,Silveira Douglas Rafaele Almeida,Velloso Elvira Deolinda Rodrigues Pereira,Rocha Vanderson,Rego Eduardo Magalhaes

Funder

fapesp

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-021-04687-6.pdf

Reference35 articles.

1. Yates JW, Wallace HJJ, Ellison RR, Holland JF (1973) Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep 57:485–488

2. DiNardo CD, Wei AH (2020) How I treat acute myeloid leukemia in the era of new drugs. Blood 135:85–96. https://doi.org/10.1182/blood.2019001239

3. Silveira DRA, Coelho-Silva JL, Silva WF et al (2021) A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings? Leuk Lymphoma 62:147–157. https://doi.org/10.1080/10428194.2020.1827252

4. Percival M-EM, Tao L, Medeiros BC, Clarke CA (2015) Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: a SEER database analysis. Cancer 121:2004–2012. https://doi.org/10.1002/cncr.29319

5. Zeidan AM, Podoltsev NA, Wang X et al (2020) Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States. Blood Adv 4:1615–1623. https://doi.org/10.1182/bloodadvances.2020001728

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Expansion of Modern AML Therapy;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia;International Journal of Molecular Sciences;2023-11-29

3. Assessing the impact of prophylactic anidulafungin during remission induction of acute myeloid leukemia – A propensity-score matching analysis;Journal of Medical Mycology;2023-11

4. Machine Learning Predicts 30-Day Outcome among Acute Myeloid Leukemia Patients: A Single-Center, Retrospective, Cohort Study;Journal of Clinical Medicine;2023-09-13

5. Are delays in diagnosis and treatment of acute leukemia in a middle-income country associated with poor outcomes? A retrospective cohort study;Hematology, Transfusion and Cell Therapy;2023-07